[go: up one dir, main page]

IN2011CH03893A - - Google Patents

Download PDF

Info

Publication number
IN2011CH03893A
IN2011CH03893A IN3893CH2011A IN2011CH03893A IN 2011CH03893 A IN2011CH03893 A IN 2011CH03893A IN 3893CH2011 A IN3893CH2011 A IN 3893CH2011A IN 2011CH03893 A IN2011CH03893 A IN 2011CH03893A
Authority
IN
India
Prior art keywords
compositions
entecavir
hepatitis
preparing
directed
Prior art date
Application number
Inventor
Reddy Bandi Parthasaradhi
Podili Khadgapathi
Nelluri Ramarao
Original Assignee
Hetero Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation
Priority to US14/357,603 priority Critical patent/US20140315930A1/en
Priority to CA2881119A priority patent/CA2881119A1/en
Priority to EP12849531.4A priority patent/EP2780001A4/en
Priority to IN3893CH2011 priority patent/IN2011CH03893A/en
Priority to PCT/IN2012/000737 priority patent/WO2013072937A2/en
Publication of IN2011CH03893A publication Critical patent/IN2011CH03893A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention is directed to fast release pharmaceutical compositions comprising entecavir or its pharmaceutically acceptable salts, process for preparing the same and use of such compositions for the treatment of Hepatitis B virus infection.
IN3893CH2011 2011-11-14 2012-11-08 IN2011CH03893A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US14/357,603 US20140315930A1 (en) 2011-11-14 2012-11-08 Fast release solid oral compositions of entecavir
CA2881119A CA2881119A1 (en) 2011-11-14 2012-11-08 Fast release solid oral compositions of entecavir
EP12849531.4A EP2780001A4 (en) 2011-11-14 2012-11-08 Fast release solid oral compositions of entecavir
IN3893CH2011 IN2011CH03893A (en) 2011-11-14 2012-11-08
PCT/IN2012/000737 WO2013072937A2 (en) 2011-11-14 2012-11-08 Fast release solid oral compositions of entecavir

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3893CH2011 IN2011CH03893A (en) 2011-11-14 2012-11-08

Publications (1)

Publication Number Publication Date
IN2011CH03893A true IN2011CH03893A (en) 2015-08-21

Family

ID=48430300

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3893CH2011 IN2011CH03893A (en) 2011-11-14 2012-11-08

Country Status (5)

Country Link
US (1) US20140315930A1 (en)
EP (1) EP2780001A4 (en)
CA (1) CA2881119A1 (en)
IN (1) IN2011CH03893A (en)
WO (1) WO2013072937A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2644196B1 (en) * 2012-03-26 2019-09-18 Arven Ilac Sanayi ve Ticaret A.S. Pharmaceutical compositions of Entecavir
CA2779052A1 (en) * 2012-05-31 2013-11-30 Pharmascience Inc. Pharmaceutical composition of entecavir and process of manufacturing
US10045993B2 (en) 2014-06-20 2018-08-14 Ctc Bio, Inc. Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251518A (en) * 1979-07-03 1981-02-17 Ralston Purina Company Method of preparing readily disintegrable pharmaceutical compositions
HRP20020649A2 (en) * 2000-02-29 2004-12-31 Bristol Myers Squibb Co Low dose entecavir formulation and use
US20070196474A1 (en) * 2004-04-30 2007-08-23 Withiam Michael C Rapidly disintegrating low friability tablets comprising calcium carbonate
CN1781485A (en) * 2005-09-02 2006-06-07 北京阜康仁生物制药科技有限公司 Improved entecavir oral disintegrating tablet and its preparing method
CN1931144A (en) * 2006-09-28 2007-03-21 河南辅仁药业集团有限公司 Entecavir effervescent tablet and its prepn process
EP2155167A2 (en) * 2007-06-04 2010-02-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
EP2465540B1 (en) * 2009-08-11 2016-10-05 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and orally rapidly disintegrating tablet
BR112012010170A2 (en) * 2009-10-28 2016-04-12 Mcneil Ppc Inc fast disintegrating / dissolving coating compositions

Also Published As

Publication number Publication date
US20140315930A1 (en) 2014-10-23
WO2013072937A2 (en) 2013-05-23
WO2013072937A3 (en) 2014-09-04
CA2881119A1 (en) 2013-05-23
EP2780001A2 (en) 2014-09-24
EP2780001A4 (en) 2015-10-28

Similar Documents

Publication Publication Date Title
PH12020550552A1 (en) Inhibitors of hepatitis c virus
IN2014MN02652A (en)
IN2014MN02658A (en)
IN2014MN02657A (en)
MD4754B1 (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
MX2012008221A (en) Inhibitors of flaviviridae viruses.
MX2012008211A (en) Inhibitors of flaviviridae viruses.
MY173422A (en) Purine derivatives for the treatment of viral infections
NZ701647A (en) Compounds and methods for antiviral treatment
MX2013006475A (en) Macrocyclic inhibitors of flaviviridae viruses.
EA026667B9 (en) Pharmaceutical composition for treating hepatitis c virus
PH12013502033A1 (en) Pyrimidine derivatives for the treatment of viral infections
MX2012000959A (en) Inhibitors of flaviviridae viruses.
NZ732391A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
IN2012DN01855A (en)
PH12015500713B1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
PH12014500385A1 (en) Benzofuran compounds for the treatment of hepatitis c virus infections
PH12016502039A1 (en) Potent and selective inhibitors of hepatitis c virus
IN2011CH03893A (en)
EA019080B9 (en) Alpha-crystalline form of carbabenzpyride